Objective To explore the safety and clinical effcacy of thalidomide combined with interleukin 2(Ⅱ-2)treatment of lung cancer complicated with malignant pleural effusion(MPE).Methods From March 2013 to March2013,60 ca...Objective To explore the safety and clinical effcacy of thalidomide combined with interleukin 2(Ⅱ-2)treatment of lung cancer complicated with malignant pleural effusion(MPE).Methods From March 2013 to March2013,60 cases of lung cancer with MPE were selected and divided into the experimental group and the展开更多
文摘Objective To explore the safety and clinical effcacy of thalidomide combined with interleukin 2(Ⅱ-2)treatment of lung cancer complicated with malignant pleural effusion(MPE).Methods From March 2013 to March2013,60 cases of lung cancer with MPE were selected and divided into the experimental group and the
